Search - sphingotec.com

81. Circulating plasma dipeptidyl dipeptidase 3 and the prognosis of cardiogenic shock

B. Raju

82. Promotion of vascular integrity in sepsis through modulation of bioactive adrenomedullin and dipeptidyl peptidase 3

van Lier D.

83. Proenkephalin (penKid®) included in the ADQI consensus statements publication as functional kidney biomarker for the management of AKI patients

SphingoTec GmbH (“SphingoTec”) announced today that the Acute Disease Quality Initiative (ADQI) recommends the use of novel biomarkers for AKI, including functional biomarkers as penKid®.

84. Uniklinik RWTH Aachen is the first hospital to implement SphingoTec's innovative biomarkers in clinical routine with the aim of making intensive care diagnostics more precise

The Uniklinik RWTH Aachen (“Uniklinik RWTH Aachen”) has successfully translated the collaboration for research and biomarker validation with SphingoTec GmbH (“SphingoTec”) into clinical routine.

85. Proenkephalin A 119-159 may predict post-operative acute kidney injury and in hospital mortality following open or endovascular thoraco-abdominal aortic repair

Gombert A.

86. Incidence and outcome of sub-clinical acute kidney injury using penKid in critically ill patients

Depret F.

87. PenKid measurement at admission is associated with outcome in severely ill burn patients

Depret F.

88. The effects of physical exercise on the assessment of kidney function

Beunders R.

89. Proenkephalin compared to conventional methods to assess kidney function in critically ill sepsis patients

Beunders R.

90. Recommendations on acute kidney injury biomarkers from the acute disease quality initiative consensus conference - a consensus statement

Ostermann M.